Correction to: Metformin in chronic kidney disease: More harm than help? [Lancet Diabetes Endocrinol 2015] Doi: 10.1016/S2213-8587(15)00133-3;Metformin in chronic kidney disease: More harm than help?

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 8, 2015, Pages 579-581

  Kalantar Zadeh, Kamyar ^a,b   Rhee, Connie M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFORMIN; CREATININE; LACTIC ACID; METFORMIN; PHENFORMIN; ANTIDIABETIC AGENT;

CHRONIC KIDNEY DISEASE; CLINICAL TRIAL (TOPIC); CREATININE BLOOD LEVEL; DEATH; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG MARKETING; DRUG RECALL; DRUG SAFETY; DRUG USE; HUMAN; HYPOGLYCEMIA; INCIDENCE; LACTIC ACIDOSIS; METABOLIC ACIDOSIS; METABOLIC DISORDER; NOTE; PRIORITY JOURNAL; RISK; CHRONIC KIDNEY FAILURE; COMPLICATION; DIABETES MELLITUS, TYPE 2; MORTALITY;

DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; RENAL INSUFFICIENCY, CHRONIC;

EID: 84938208849     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00257-0     Document Type: Erratum

References (9)

1. Kalantar-Zadeh K, Uppot RN, Lewandrowski KB Case records of the Massachusetts General Hospital: case 23-2013-a 54-year-old woman with abdominal pain, vomiting, and confusion. N Engl J Med 2013, 369:374-382.
2. Vecchio S, Protti A Metformin-induced lactic acidosis: no one left behind. Crit Care 2011, 15:107.
3. Fimognari FL, Corsonello A, Pastorell R, Antonelli-Incalzi R Metformin-induced pancreatitis: a possible adverse drug effect during acute renal failure. Diabetes Care 2006, 29:1183.
4. Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA 2014, 312:2668-2675.
5. Hung S-C, Chang Y-K, Liu J-S, et al. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study. Lancet Diabetes Endocrinol 2015, published online June 18. http://dx.doi.org/10.1016/S2213-8587(15)00123-0.
6. Rhee CM, Leung AM, Kovesdy CP, Lynch KE, Brent GA, Kalantar-Zadeh K Updates on the management of diabetes in dialysis patients. Semin Dial 2014, 27:135-145.
7. Park J, Lertdumrongluk P, Molnar MZ, Kovesdy CP, Kalantar-Zadeh K Glycemic control in diabetic dialysis patients and the burnt-out diabetes phenomenon. Curr Diab Rep 2012, 12:432-439.
8. De Deyn PP, Vanholder R, Eloot S, Glorieux G Guanidino compounds as uremic (neuro)toxins. Semin Dial 2009, 22:340-345.
9. Bren L Frances Oldham Kelsey: FDA medical reviewer leaves her mark on history. FDA Consum 2001, 35:24-29.